Trial intelligence / Profile preview

Crisaborole for scratch and sleep in pediatric atopic dermatitis

NCT05200403Phase 4Terminated

Sponsor
Boston University
Start
Jul 2022
Primary completion
Feb 2024
Countries
1
01

Overview

A Phase 4 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Boston University. Started Jul 2022; status: terminated.

02

Drugs

AN2728 ointment vehicle
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT05200403.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05200403.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call